Mounjaro Approval Takes Global Obesity Battle To China

New Policies Also Released

The global battle of the blockbuster obesity drugs appears set to come to China with the approval of Lilly's Mounjaro, although domestic competitors are fast catching up. 

Obesity
Lilly gains China Mounjaro approval but Chinese domestic competition is fast increasing • Source: Shutterstock

More from China

More from Focus On Asia